The Fujirebio Diagnostics HE4 test has been cleared by the US FDA for use as an aid in monitoring recurrence or progressive disease in patients with epithelial ovarian cancer. The test can currently be ordered exclusively through Quest Diagnostics.
This is the same company that makes the CA125. I will be sure to ask my doc about it on my next visit...have any of you had this done yet?
Here's some additional information. http://www.questdiagnostics.com/hcp/intguide/jsp/showintguidepage.jsp?fn=He matOnc/Ovary/TS_HE4_Ovarian_Cancer_Monitoring.htm
We're getting closer every day!!!